Our findings demonstrate that PTEN inhibits ASM proliferation and migration in vitro and airway remodeling in vivo through the downregulation of CD38-mediated Ca2+/CREB signaling, which underscores the a key role of PTEN/CD38/Ca2+/CREB signaling in the molecular pathogenesis of asthma. Here, CREB1 is linked to asthma.